Human embryonic stem cell lines created that avoid immune rejection

Dec 20, 2007

In a groundbreaking experiment published in Cloning & Stem Cells, scientists from International Stem Cell (ISC) Corp. derived four unique embryonic stem cell lines that open the door for the creation of therapeutic cells that will not provoke an immune reaction in large segments of the population. The stem cell lines are “HLA-homozygous,” meaning that they have a simple genetic profile in the critical areas of the DNA that code for immune rejection.

The lines could serve to create a stem cell bank as a renewable source of transplantable cells for use in cell therapy to replace damaged tissues or to treat genetic and degenerative diseases.

“This study has used a novel approach to producing cells that may one day be used to treat large numbers of patients. While there is a great deal of discussion about the possibility of producing stem cells for each patient this approach to therapy is unrealistic because of the enormous costs involved. Rather it is likely that treatment of large numbers of patients by cell therapy will only be possible if methods are found using any one cell line to treat very large numbers of patients. This very exciting paper represents a significant step forward towards the use of such cells in cell therapy,” says Ian Wilmut, PhD, journal Editor-in-Chief and Director of the Centre for Regenerative Medicine at the Queen’s Medical Research Institute, University of Edinburgh.

“Immune reaction is one of the most serious problems facing the development of stem cell therapy, and cell lines of this type may enable us to treat a large number of patients without immune rejection, offering an enormous practical advantage. Further research is required to confirm that the cells produced in this way are able to replace cells that have been lost in human degenerative disease.”

Jeffrey Janus, President of International Stem Cell and colleagues at the company and from the Russian Academy of Medical Sciences, described the successful parthenogenetic activation of human oocytes and the subsequent derivation of cell lines having the morphology and markers characteristic of human embryonic stem cells. In a paper entitled, “HLA Homozygous Stem Cell Lines Derived from Human Parthenogenetic Blastocysts,” the authors emphasize two key factors that would make this technology so valuable for future efforts to generate replacement tissues and organs and to use donor-derived cell repositories to develop cell-based therapies.

First, the four human parthenogenetic stem cell lines, designated as HpSC-Hhom, are HLA (human leukocyte antigen) homozygous. This makes it possible to match the HLA types of a donor and recipient, reducing the chances of provoking an immune reaction against the transplanted donor cells.

Second, the stem cells are derived from unfertilized donor eggs, not from fertilized embryos, so the technique does not carry the same ethical burden.

The future clinical relevance of this work will depend on the ability to reproduce these results and to demonstrate that the stem cell lines can be induced to form pluripotent progenitor cells and, ultimately, to differentiate into specific mature cell types that can be safely and successfully delivered to patients.

The paper was published online ahead of print in the Journal and is available online. The paper is part of the Spring 2008 (Volume 10, Number 1) issue of the Journal, which is published by Mary Ann Liebert, Inc.

External link: www.liebertpub.com/publication.aspx?pub_id=9

Source: Mary Ann Liebert, Inc.

Explore further: Landless Brazilians in GM eucalyptus protest

add to favorites email to friend print save as pdf

Related Stories

Sall4 is required for DNA repair in stem cells

Mar 02, 2015

A protein that helps embryonic stem cells (ESCs) retain their identity also promotes DNA repair, according to a study in The Journal of Cell Biology. The findings raise the possibility that the protein, Sall4, ...

Seven strategies to advance women in science

Mar 05, 2015

Despite the progress made by women in science, engineering, and medicine, a glance at most university directories or pharmaceutical executive committees tells the more complex story. Women in science can ...

Activating genes on demand

Mar 04, 2015

When it comes to gene expression - the process by which our DNA provides the recipe used to direct the synthesis of proteins and other molecules that we need for development and survival - scientists have ...

Recommended for you

Landless Brazilians in GM eucalyptus protest

5 hours ago

Members of a landless peasant group, some wielding sticks or knives, attacked a cellulose factory in a violent protest against its use of genetically engineered eucalyptus plants, video released by organizers ...

Is the tasty blue crab's natural range creeping north?

7 hours ago

David Johnson was standing in a salt marsh tidal creek north of Boston, Mass., when he scooped up a blue crab, Callinectes sapidus, 80 miles north of its native range. The northern migration of this commer ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.